科普專欄–薯不揀單 - 深入淺出–以免疫治療(Immunotherapy)手段醫治癌細胞(二)

上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1413Please respect copyright.ＰＥＮＡＮＡqk5HIAXuW0
1413Please respect copyright.ＰＥＮＡＮＡ0PVh3JWqun
上集：https://www.penana.com/article/4711251413Please respect copyright.ＰＥＮＡＮＡznMtMJBvSH
1413Please respect copyright.ＰＥＮＡＮＡ0Yyus8BttR
1413Please respect copyright.ＰＥＮＡＮＡh3SLe9JRtv
1413Please respect copyright.ＰＥＮＡＮＡLnxu1DsxzV
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1413Please respect copyright.ＰＥＮＡＮＡG8CuUooBnQ
1413Please respect copyright.ＰＥＮＡＮＡ9hvI7ocjWF
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1413Please respect copyright.ＰＥＮＡＮＡfYJijROsDW
1413Please respect copyright.ＰＥＮＡＮＡX13b3RnnLk
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1413Please respect copyright.ＰＥＮＡＮＡxzuV0ZHoZi
1413Please respect copyright.ＰＥＮＡＮＡFFUc8sAh7j
1413Please respect copyright.ＰＥＮＡＮＡxzMzIJdTBK
1413Please respect copyright.ＰＥＮＡＮＡIYi9c6aVkn
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1413Please respect copyright.ＰＥＮＡＮＡHtKsUTISp9
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1413Please respect copyright.ＰＥＮＡＮＡiWiZJ4yRe4
1413Please respect copyright.ＰＥＮＡＮＡYRbqmEDWPg
忘記甚麼是Neoantigen的話，可重溫上一集。1413Please respect copyright.ＰＥＮＡＮＡvJOY4b4FkE
1413Please respect copyright.ＰＥＮＡＮＡyb3PYD3RA6
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1413Please respect copyright.ＰＥＮＡＮＡ0IRQZ6OIVP
1413Please respect copyright.ＰＥＮＡＮＡB4gxX2ClGj
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1413Please respect copyright.ＰＥＮＡＮＡ7kF1OuT1sS
1413Please respect copyright.ＰＥＮＡＮＡqI00poP2oq
1413Please respect copyright.ＰＥＮＡＮＡ10AnXy1e8S
1413Please respect copyright.ＰＥＮＡＮＡ8ksQD0nlNN
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1413Please respect copyright.ＰＥＮＡＮＡeNDJ7FCKZX
1413Please respect copyright.ＰＥＮＡＮＡsNk9TphcAG
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1413Please respect copyright.ＰＥＮＡＮＡC0NBlkcwCK
1413Please respect copyright.ＰＥＮＡＮＡtPJBIn51bf
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1413Please respect copyright.ＰＥＮＡＮＡEF7Fq6i9vd
1413Please respect copyright.ＰＥＮＡＮＡ7l9K8LUA6G
1413Please respect copyright.ＰＥＮＡＮＡgp47ygIbg4
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1413Please respect copyright.ＰＥＮＡＮＡSceDN3enVj
1413Please respect copyright.ＰＥＮＡＮＡYvQ1RtBYE4
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1413Please respect copyright.ＰＥＮＡＮＡx27P8xtlc7
1413Please respect copyright.ＰＥＮＡＮＡxkkUtHBHQB
1413Please respect copyright.ＰＥＮＡＮＡqTN2GmVZTw
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1413Please respect copyright.ＰＥＮＡＮＡaLv79MQtyX
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1413Please respect copyright.ＰＥＮＡＮＡffAPy07kmH
1413Please respect copyright.ＰＥＮＡＮＡQofTVjYRax
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1413Please respect copyright.ＰＥＮＡＮＡFfqmAHGNCi
1413Please respect copyright.ＰＥＮＡＮＡgQKo1AvoVO
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1413Please respect copyright.ＰＥＮＡＮＡuASoIa1Al7
1413Please respect copyright.ＰＥＮＡＮＡX9oQqauJGG
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1413Please respect copyright.ＰＥＮＡＮＡtDzwh7jAil
1413Please respect copyright.ＰＥＮＡＮＡ0mDhYL5AIT
1413Please respect copyright.ＰＥＮＡＮＡfcn4OA2wNN
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1413Please respect copyright.ＰＥＮＡＮＡBGegGclQfN
1413Please respect copyright.ＰＥＮＡＮＡuLK3zRT8wd
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1413Please respect copyright.ＰＥＮＡＮＡHxSjFkgY1e
1413Please respect copyright.ＰＥＮＡＮＡ53ABGDUcUd
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1413Please respect copyright.ＰＥＮＡＮＡUYLfEIFAoW
1413Please respect copyright.ＰＥＮＡＮＡ64cBbreems
Link:1413Please respect copyright.ＰＥＮＡＮＡ9qszU8evZn
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1413Please respect copyright.ＰＥＮＡＮＡyNobmLVIRT
1413Please respect copyright.ＰＥＮＡＮＡyChK7uIMS3
1413Please respect copyright.ＰＥＮＡＮＡQBZzQxXn9O
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1413Please respect copyright.ＰＥＮＡＮＡBy0YMoxRti